Electronic symptom monitoring for patients with advanced cancer

Author:

Liu Liu12,Wang Tianyi1,Chen Yue1,Cao Yubin13

Affiliation:

1. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases; West China Hospital of Stomatology, Sichuan University; Chengdu China

2. Department of Conservative Dentistry and Endodontics; West China Hospital of Stomatology, Sichuan University; Chengdu China

3. Department of Oral and Maxillofacial Surgery; West China Hospital of Stomatology, Sichuan University; Chengdu China

Publisher

Wiley

Subject

Pharmacology (medical)

Reference98 articles.

1. Cabozantinib in patients with advanced and progressing hepatocellular carcinoma;Abou-Alfa;The New England Journal of Medicine,2018

2. Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised controlled trial in systemic cancer treatment;Absolom;BMC Cancer,2017

3. Advances in radiotherapy;Ahmad;BMJ,2012

4. American Cancer Society What is advanced cancer? https://www.cancer.org/treatment/understanding-your-diagnosis/advanced-cancer/what-is.html (assessed 15 November 2022)

5. Patient-reported outcomes and health-related quality of life following radiotherapy for bladder cancer;Appleyard;Clinical Oncology (Royal College of Radiologists (Great Britain)),2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3